Ensign Peak Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $400M | Buy |
|
|||||
|
2025
Q1 | $445M | Buy |
|
|||||
|
2024
Q4 | $366M | Buy |
|
|||||
|
2024
Q3 | $401M | Sell |
|
|||||
|
2024
Q2 | $356M | Sell |
|
|||||
|
2024
Q1 | $383M | Buy |
|
|||||
|
2023
Q4 | $306M | Sell |
|
|||||
|
2023
Q3 | $348M | Buy |
|
|||||
|
2023
Q2 | $244M | Sell |
|
|||||
|
2023
Q1 | $405M | Sell |
|
|||||
|
2022
Q4 | $464M | Buy |
|
|||||
|
2022
Q3 | $380M | Sell |
|
|||||
|
2022
Q2 | $563M | Buy |
|
|||||
|
2022
Q1 | $543M | Buy |
|
|||||
|
2021
Q4 | $369M | Buy |
|
|||||
|
2021
Q3 | $243M | Buy |
|
|||||
|
2021
Q2 | $194M | Buy |
|
|||||
|
2021
Q1 | $175M | Buy |
|
|||||
|
2020
Q4 | $167M | Buy |
|
|||||
|
2020
Q3 | $75M | Buy |
|
|||||
|
2020
Q2 | $68.7M | Buy |
|
|||||
|
2020
Q1 | $28.7M | Sell |
|
|||||
|
2019
Q4 | $42.5M | Buy |
|